| 摘要 |
The present invention relates to a method of treating depression or anxiety in a mammal, including a human, by administering to the mammal a GABA-A alpha 2/3 agonist in combination with an SRI antidepressant agent with improvement in efficacy. I t also relates to pharmaceutical compositions containing a pharmaceutically acceptable carrier , a GABA-A alpha 2/3 agonist, and an SRI antidepressant agent.
|
